Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Other financing activities (2016 - 2019)

Organogenesis Holdings has reported Other financing activities over the past 4 years, most recently at $2.0 million for Q4 2019.

  • Quarterly results put Other financing activities at $2.0 million for Q4 2019, changed N/A from a year ago — trailing twelve months through Dec 2019 was $3.0 million (up 1579.66% YoY), and the annual figure for FY2020 was $5.7 million, up 90.25%.
  • Other financing activities for Q4 2019 was $2.0 million at Organogenesis Holdings, up from $75000.0 in the prior quarter.
  • Over the last five years, Other financing activities for ORGO hit a ceiling of $2.0 million in Q4 2019 and a floor of $9000.0 in Q1 2018.
  • Median Other financing activities over the past 4 years was $122000.0 (2018), compared with a mean of $405819.9.
  • Biggest five-year swings in Other financing activities: crashed 97.9% in 2018 and later surged 8911.11% in 2019.
  • Organogenesis Holdings' Other financing activities stood at $294019.0 in 2016, then surged by 94.69% to $572422.0 in 2017, then crashed by 91.96% to $46000.0 in 2018, then skyrocketed by 4354.35% to $2.0 million in 2019.
  • The last three reported values for Other financing activities were $2.0 million (Q4 2019), $75000.0 (Q3 2019), and $38000.0 (Q2 2019) per Business Quant data.